Pharmacotherapeutic stature of doxazosin and its role in coronary risk reduction
- 31 December 1988
- journal article
- review article
- Published by Elsevier in American Heart Journal
- Vol. 116 (6) , 1735-1747
- https://doi.org/10.1016/0002-8703(88)90223-2
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- Clinical experience with doxazosin in general medical practiceAmerican Heart Journal, 1988
- Pharmacokinetic overview of doxazosinThe American Journal of Cardiology, 1987
- Coronary artery disease risk factor management in the hypertensive patientThe American Journal of Cardiology, 1987
- Effects of Doxazosin on Vascular Collagen Synthesis, Arterial Pressure and Serum Lipids in the Spontaneously Hypertensive RatJournal of Cardiovascular Pharmacology, 1987
- The pharmacokinetics of doxazosin in elderly normotensives.British Journal of Clinical Pharmacology, 1986
- Clinical Pharmacology and Therapeutic Role of Prazosin and Related Alpha-Adrenoceptor AntagonistsCardiology, 1986
- Application of Pharmacokinetic-Pharmacodynamic Modelling for the Comparison of Quinazoline α-Adrenoceptor Agonists in Normotensive VolunteersJournal of Cardiovascular Pharmacology, 1985
- Postjunctional Selectivity of α-Blockade with Prazosin, Trimazosin, and UK-33,274 in ManJournal of Cardiovascular Pharmacology, 1982
- Determination of the vasodilator UK33274 by high-performance liquid chromatography using fluorescence detectionJournal of Chromatography B: Biomedical Sciences and Applications, 1980
- EFFECT OF PROPRANOLOL AND PRAZOSIN ON BLOOD LIPIDSThe Lancet, 1980